看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBIT Multiple | 15.5x - 17.2x | 16.4x |
| Selected Fwd EBIT Multiple | 10.8x - 11.9x | 11.4x |
| Fair Value | $59.88 - $69.64 | $64.76 |
| Upside | -7.1% - 8.0% | 0.5% |
| Benchmarks | Ticker | Full Ticker |
| Envista Holdings Corporation | NVST | NYSE:NVST |
| Enovis Corporation | ENOV | NYSE:ENOV |
| ZimVie Inc. | ZIMV | NasdaqGS:ZIMV |
| HealthLynked Corp. | HLYK | PINC:HLYK |
| Treace Medical Concepts, Inc. | TMCI | NasdaqGS:TMCI |
| Henry Schein, Inc. | HSIC | NasdaqGS:HSIC |
| - | - | - |
| Select LTM EBIT Multiple | |||||||
| Benchmark Companies | |||||||
| NVST | ENOV | ZIMV | HLYK | TMCI | HSIC | ||
| NYSE:NVST | NYSE:ENOV | NasdaqGS:ZIMV | PINC:HLYK | NasdaqGS:TMCI | NasdaqGS:HSIC | ||
| Historical EBIT Growth | |||||||
| 5Y CAGR | -8.8% | -30.7% | NM- | NM- | NM- | 0.4% | |
| 3Y CAGR | -25.1% | NM- | NM- | NM- | NM- | -4.6% | |
| Latest Twelve Months | -52.2% | 836.6% | 81.3% | -3.4% | -8.2% | 2.5% | |
| Historical EBIT Profit Margin | |||||||
| 5 Year Average Margin | 11.8% | 1.6% | -1.8% | -83.0% | -20.8% | 6.3% | |
| Prior Fiscal Year | 12.8% | -0.4% | -2.5% | -67.0% | -27.5% | 5.9% | |
| Latest Fiscal Year | 6.2% | 2.6% | -0.5% | -131.7% | -26.6% | 5.9% | |
| Latest Twelve Months | 6.2% | 2.6% | -0.5% | -131.7% | -26.6% | 5.9% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 1.34x | 1.60x | 0.93x | 3.52x | 2.23x | 0.95x | |
| EV / LTM EBITDA | 12.0x | 9.9x | 13.0x | -2.8x | -9.7x | 11.9x | |
| EV / LTM EBIT | 21.5x | 62.2x | -199.5x | -2.7x | -8.4x | 16.1x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBIT | -199.5x | -2.7x | 62.2x | ||||
| Historical EV / LTM EBIT | 14.4x | 15.4x | 19.0x | ||||
| Selected EV / LTM EBIT | 15.5x | 16.4x | 17.2x | ||||
| (x) LTM EBIT | 746 | 746 | 746 | ||||
| (=) Implied Enterprise Value | 11,591 | 12,201 | 12,811 | ||||
| (-) Non-shareholder Claims * | (4,025) | (4,025) | (4,025) | ||||
| (=) Equity Value | 7,566 | 8,176 | 8,786 | ||||
| (/) Shares Outstanding | 122.5 | 122.5 | 122.5 | ||||
| Implied Value Range | 61.76 | 66.74 | 71.72 | ||||
| FX Rate: USD/USD | 1.0 | 1.0 | 1.0 | Market Price | |||
| Implied Value Range (Trading Cur) | 61.76 | 66.74 | 71.72 | 64.46 | |||
| Upside / (Downside) | -4.2% | 3.5% | 11.3% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | NVST | ENOV | ZIMV | HLYK | TMCI | HSIC | |
| Enterprise Value | 3,248 | 3,314 | 383 | 9 | 455 | 11,922 | |
| (+) Cash & Short Term Investments | 1,069 | 48 | 75 | 0 | 76 | 122 | |
| (+) Investments & Other | 0 | 20 | 26 | 0 | 0 | 170 | |
| (-) Debt | (1,548) | (1,404) | (233) | (4) | (70) | (2,873) | |
| (-) Other Liabilities | 0 | (2) | 0 | 0 | 0 | (1,444) | |
| (-) Preferred Stock | 0 | 0 | 0 | (0) | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 2,769 | 1,976 | 252 | 5 | 461 | 7,897 | |
| (/) Shares Outstanding | 169.5 | 57.1 | 27.8 | 281.9 | 62.9 | 122.5 | |
| Implied Stock Price | 16.34 | 34.60 | 9.04 | 0.02 | 7.34 | 64.46 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 16.34 | 34.60 | 9.04 | 0.02 | 7.34 | 64.46 | |
| Trading Currency | USD | USD | USD | USD | USD | USD | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |